Pathological implications of cell cycle re-entry in Alzheimer disease
暂无分享,去创建一个
Xiongwei Zhu | Wataru Kudo | Hyoung-Gon Lee | Xiongwei Zhu | Mark A. Smith | D. Bonda | Hyoung-gon Lee | David J. Bonda | Hyun-pil Lee | Wataru Kudo | Hyun-pil Lee
[1] Hyoung-Gon Lee,et al. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. , 2007, Biochimica et biophysica acta.
[2] R. Neve,et al. Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis. , 2007, Biochimica et biophysica acta.
[3] B. Breuer,et al. The Relationship of Tamoxifen with Dementia, Depression, and Dependence in Activities of Daily Living in Elderly Nursing Home Residents , 2000, Women & health.
[4] Yufei Wang,et al. Neuronal binucleation in Alzheimer disease hippocampus , 2008, Neuropathology and applied neurobiology.
[5] Hyoung-Gon Lee,et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease , 2009, Aging.
[6] S. Arlt,et al. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .
[7] Hui Zheng,et al. Presenilin 1 Negatively Regulates β-Catenin/T Cell Factor/Lymphoid Enhancer Factor-1 Signaling Independently of β-Amyloid Precursor Protein and Notch Processing , 2001, The Journal of cell biology.
[8] F. Nicoletti,et al. Mitotic signaling by beta-amyloid causes neuronal death. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] G. Perry,et al. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. , 2000, Journal of neuropathology and experimental neurology.
[10] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[11] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[12] Xiongwei Zhu,et al. Increased Expression of p130 in Alzheimer Disease , 2007, Neurochemical Research.
[13] M. Smith,et al. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.
[14] G. Cole,et al. Amyloid beta protein precursor is a mitogen. , 1989, Biochemical and biophysical research communications.
[15] G. Jicha,et al. Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.
[16] A. Smith,et al. Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.
[17] Hyoung-Gon Lee,et al. BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease , 2007, International journal of medical sciences.
[18] M. Lynch,et al. Neuroinflammatory changes increase the impact of stressors on neuronal function. , 2009, Biochemical Society transactions.
[19] D. Morgan. The role of microglia in antibody-mediated clearance of amyloid-beta from the brain. , 2009, CNS & neurological disorders drug targets.
[20] Xiongwei Zhu,et al. Apoptosis in Alzheimer disease: a mathematical improbability. , 2006, Current Alzheimer research.
[21] J. Brion. Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[22] Xiongwei Zhu,et al. Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.
[23] G. Perry,et al. Apoptosis and Alzheimer's disease [5] , 1998 .
[24] P. Coleman,et al. Neurons may live for decades with neurofibrillary tangles. , 1999, Journal of neuropathology and experimental neurology.
[25] H. Orr,et al. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice , 1992, Neuron.
[26] R. Castellani,et al. Alzheimer disease. , 2010, Disease-a-month : DM.
[27] Xiongwei Zhu,et al. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease , 2004, Journal of neuroscience research.
[28] K. Herrup,et al. Aβ Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[29] Peter Davies,et al. Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice , 2007, The Journal of Neuroscience.
[30] Xiongwei Zhu,et al. Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. , 2002, Science of aging knowledge environment : SAGE KE.
[31] U. Gärtner,et al. Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration , 1999, Neuroscience.
[32] M. Al-Ubaidi,et al. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[33] Jinhe Li,et al. Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation , 1997, Cell.
[34] David S. Park,et al. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment , 2000, Neurobiology of Aging.
[35] C. Dang,et al. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.
[36] Y. Christen,et al. Genetics and Alzheimer’s Disease , 1988, Research and Perspectives in Alzheimer’s Disease.
[37] Xiongwei Zhu,et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis , 2001, Mechanisms of Ageing and Development.
[38] K. Zou,et al. A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.
[39] S. Pulst,et al. The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. , 1989, Genomics.
[40] G. Perry,et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. , 2008, CNS & neurological disorders drug targets.
[41] K. Herrup,et al. DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease , 2001, The Journal of Neuroscience.
[42] M. Viitanen,et al. Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease , 2009, Neurochemistry International.
[43] G. Perry,et al. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? , 2003, Acta Neuropathologica.
[44] George Perry,et al. Distribution, levels, and activation of MEK1 in Alzheimer's disease , 2003, Journal of neurochemistry.
[45] I. Ferrer,et al. Phosphorylated c‐MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration , 2001, Neuropathology and applied neurobiology.
[46] M. Smith,et al. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. , 1999, Medical hypotheses.
[47] S. Schippling,et al. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. , 2001, Free radical biology & medicine.
[48] Hyoung-Gon Lee,et al. Oxidative imbalance in alzheimer’s disease , 2007, Molecular Neurobiology.
[49] J. Brion,et al. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons , 1994, Neuroscience.
[50] F. Nicoletti,et al. Mitotic signaling by β‐amyloid causes neuronal death , 1999 .
[51] C. Lippa,et al. Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders , 1995, Journal of neuropathology and experimental neurology.
[52] David S. Park,et al. Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.
[53] Hyoung-Gon Lee,et al. Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. , 2008, International journal of clinical and experimental pathology.
[54] J. Brioni,et al. and Alzheimer's disease , 2010 .
[55] P. Davies,et al. Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.
[56] G. Evan,et al. Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.
[57] C. Behl,et al. Apoptosis and Alzheimer's disease , 2000, Journal of Neural Transmission.
[58] Mark A. Smith,et al. Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration , 2002, Neuroscience Letters.
[59] Mark A. Smith,et al. Premature centromere division of the X chromosome in neurons in Alzheimer’s disease , 2008, Journal of neurochemistry.
[60] S. Janicki,et al. Familial Alzheimer’s disease presenilin-1 mutants potentiate cell cycle arrest , 2000, Neurobiology of Aging.
[61] A. A. Farooqui,et al. Iron, neuroinflammation, and Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.
[62] George Perry,et al. Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.
[63] Jack Woods,et al. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. , 2007, Biochimica et biophysica acta.
[64] X. Graña,et al. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.
[65] K. Herrup,et al. Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models , 2006, The Journal of Neuroscience.
[66] S. Janicki,et al. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. , 1999, The American journal of pathology.
[67] G. Perry,et al. Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .
[68] Xiongwei Zhu,et al. Cell cycle events in neurons. Proliferation or death? , 1999, The American journal of pathology.
[69] P. Eikelenboom. Neuroinflammation and Alzheimer’s Disease , 1997 .
[70] Hyoung-Gon Lee,et al. Growth Factors , Cytokines , Cell Cycle Molecules The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse , 2010 .
[71] M. Smith,et al. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. , 2007, CNS & neurological disorders drug targets.
[72] T. Arendt,et al. Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease , 2007, The Journal of Neuroscience.
[73] C. Masters,et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.
[74] K. Herrup,et al. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. , 2009, The Journal of clinical investigation.
[75] A. Smith,et al. Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.
[76] H. Wiśniewski,et al. Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition , 2004, Acta Neuropathologica.